Company: SVREW
Filing Date: 2025-04-03
Form Type: 424B3
Source: 0001213900-25-028398
Chunk: 14

Company: SaverOne 2014 Ltd.
Filing Date: 2025-04-03
Form: 424B3
Chunk 14
---
 was below $1.00 for 30 consecutive business days. Because we effected the 2024 Reverse Stock Split within the prior one-year period, under a recently amended Listing Rule 5810(c)(3)(A)(iv), the Company was not eligible to receive any new compliance or a cure period by the Nasdaq Staff. Accordingly, our ADSs were subject to delisting from Nasdaq unless we requested an appeal of this determination. On February 27, 2025, we requested an appeal, and a hearing date was scheduled for April 10, 2025.

On February 21, 2025, we implemented the 2025 Reverse Stock Split in order to regain compliance with the Minimum Bid Price Requirement. On March 14, 2025, the Nasdaq Staff notified the Company that it has regained compliance with the Minimum Bid Price Requirement and that the hearing has accordingly been cancelled.

Corporate Information

Our main business activities are conducted in Israel. Our corporate headquarters are located at Em Hamoshavot Rd. 94. Petah Tikvah, Israel, where we currently occupy approximately 495 square meters. We lease our facilities and our lease ends on June 30, 2027. Our current monthly rent payment is NIS 49,000 (approximately $13,500).

We consider that our current office space is sufficient to meet our anticipated needs for the foreseeable future and is suitable for the conduct of our business.

<div align='center'>5</div>

Summary of Risk Factors Our business is subject to numerous risks and uncertainties, including those highlighted in the section titled “Risk Factors” below and other risk factors contained in the documents incorporated by reference hereinbefore deciding whether to invest in our securities. These risks include, among others, the following: Risks Related to Our Financial Condition and this Offering.

| ● | We have a limited operating                                                                                                      
 history on which to assess the prospects for our business, have incurred significant losses since the date of our inception, and 
 anticipate that we will continue to incur significant losses until we are able to successfully commercialize our products.       |
| ● | Our independent auditors                                                                                                         
 have expressed their concern as to our ability to continue as a going concern.                                                   |

| ● | We                                                                                                                                    
 may not be able to continue complying with the continued Nasdaq listing requirements which could result in delisting of the ADSs from 
 Nasdaq.                                                                                                                               |

| ● | Sales of a substantial                                                                                                                        
 amount of our Ordinary Shares or ADSs,